Table 1 Patient characteristics (n=86)

From: Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast cancer patients

 

Mean (range) or n (%)

Missing data n

Age at diagnosis (years)

49 (26–76)

0

Ethnic group

0

 Caucasian

66 (77%)

 

 North African and sub-Saharan African

19 (22%)

 

 Asian

1 (1%)

 

Menopausal status a

0

 Premenopausal

53 (62%)

 

 Postmenopausal

33 (38%)

 

Age at menopause (years)

49 (42–59)

10

Height (cm)

163 (149–177)

0

Weight (kg)

67 (46–137)

0

BMI (kg m−2)

25 (18–53)

0

Age at menarche (years)

13 (10–18)

42

Age at full-term pregnancy (years)

26 (15–37)

19

Parity

2 (0–10)

6

Ever hormone replacement therapy use

13 (48%)

6

Current smoker

11 (17%)

22

Tumour stage (T)

0

 T2 (size >20 mm and 50 mm)

53 (62%)

 

 T3 (size >50 mm)

25 (29%)

 

 T4 (inflammatory)

8 (9%)

 

Histologic type of breast cancer

0

 IDC

76 (88%)

 

 ILC

10 (12%)

 
  1. Abbreviations: BMI=body mass index; IDC=invasive ductal carcinoma; ILC=invasive lobular carcinoma.
  2. aMenopausal status refers to the menopausal status at the time of diagnosis. Menopause was defined as amenorrhea for at least 12 months.